ICH S1A Need for carcinogenicity studies of pharmaceuticals

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/ICH/140/95
Effective from01/12/2013
KeywordsCarcinogenicity studies, tumorigenic potential, duration of treatment, genotoxicity
DescriptionThis document defines the conditions under which carcinogenicity studies should be conducted to avoid the unnecessary use of animals in testing.

Related content

How helpful is this page?

Average rating:

 Based on 40 ratings

Add your rating:

See all ratings
8 ratings
8 ratings
8 ratings
8 ratings
8 ratings

Tell us more